This document includes our analysis of several data sets as well as a list of the 85 ASCO data events we have inputted into BioMedTracker to date. Below are some of the key highlights from this weekend’s presentations. Additional analyses will follow in the coming days. Please download the PDF on the upper right for the full report.

Key Drugs
• Ipilimumab (BMS) for Melanoma

• Avastin (Roche) for Ovarian Cancer

• Revlimid (CELG) for Multiple Myeloma

• Delcath PHP system with melphalan (DCTH) for Melanoma

• PCI-32765 (PCYC) for Chronic Lymphocytic Leukemia (CLL)

• GSK1120212 (GSK) for Melanoma

• Jevtana (SNY) for Prostate Cancer